Pharmacogenetics: Ethical issues

Bioethics

Volumn 18, Issue 4, 2004, Pages

  Sutrop, Margit ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DRUG; PENICILLIN G; VACCINE;

DRUG COST; DRUG DESIGN; DRUG INDUSTRY; DRUG RESPONSE; EDITORIAL; ETHICS; GENETIC POLYMORPHISM; GENOTYPE; HISTORY; JUSTICE; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RESEARCH; NOMENCLATURE; PHARMACOGENETICS; PHARMACOGENOMICS; QUALITY OF LIFE; SOCIETY; TECHNOLOGY;

EID: 3342882576     PISSN: 02699702     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-8519.2004.00398.x     Document Type: Editorial

References (12)

1. Unfortunately, this optimism is justified only in some parts of the world. Major killing diseases in developing countries are under researched, and access to available medicines is lacking due to grave poverty.
2. According to a recent study in the USA, adverse drug reactions cause about 100 000 deaths per year.
3. D.W. Nebert. Pharmacogenetics and Pharmacogenomics: Why is this Relevant to the Clinical Geneticist? Clinical Genetics 1999; 56: 247-258.
4. F. Vogel. Moderne Probleme der Humangenetik. Ergebnisse der Inneren Medizin in Kinderheikunde 1959; 12: 52-125.
5. A good historical overview of pharmacogenetics and pharmacogenomics can be found in: M. Pirmohamed. Pharmacogenetics and Pharmacogenomics. British Journal of Clinical Pharmacology 2001; 52: 345-347.
6. K. Lindpainter. The Impact of Pharmacogenetics and Pharmacogenomics on Drug Discovery. Nature Reviews 2002; 1: 463-469.
7. See for example: Consortium on Pharmacogenetics. 2002. Pharmacogenetics: Ethical and Regulatory Issues in Research and Clinical Practice; A. Buchanan, A. Califano, J. Kahn, E. McPherson, J. Robertson & B. Brody. Pharmacogenetics: Ethical Issues and Policy Options. Kennedy Institute of Ethics Journal 2002; 12: 1-15. My Very Own Medicine: What Must I Know? Information Policy for Pharmacogenetics. 2003. Cambridge. University of Cambridge Press; Nuffield Council on Bioethics. 2003. Pharmacogenetics: Ethical Issues. London. Nuffield Council on Bioethics; M. Rothstein, ed. 2003. Pharmacogenomics: Social, Ethical and Clinical Dimensions. New Jersey. Wiley-Liss, A John Wiley & Sons; N.W. Paul & A.D. Roses. Pharmacogenetics and Pharmacogenomics: Recent Developments, their Clinical Relevance and some Ethical, Social, and Legal Implications. Journal of Molecular Medicine 2003; 81: 135-140.
8. See for example: Consortium on Pharmacogenetics. 2002. Pharmacogenetics: Ethical and Regulatory Issues in Research and Clinical Practice; A. Buchanan, A. Califano, J. Kahn, E. McPherson, J. Robertson & B. Brody. Pharmacogenetics: Ethical Issues and Policy Options. Kennedy Institute of Ethics Journal 2002; 12: 1-15. My Very Own Medicine: What Must I Know? Information Policy for Pharmacogenetics. 2003. Cambridge. University of Cambridge Press; Nuffield Council on Bioethics. 2003. Pharmacogenetics: Ethical Issues. London. Nuffield Council on Bioethics; M. Rothstein, ed. 2003. Pharmacogenomics: Social, Ethical and Clinical Dimensions. New Jersey. Wiley-Liss, A John Wiley & Sons; N.W. Paul & A.D. Roses. Pharmacogenetics and Pharmacogenomics: Recent Developments, their Clinical Relevance and some Ethical, Social, and Legal Implications. Journal of Molecular Medicine 2003; 81: 135-140.
9. See for example: Consortium on Pharmacogenetics. 2002. Pharmacogenetics: Ethical and Regulatory Issues in Research and Clinical Practice; A. Buchanan, A. Califano, J. Kahn, E. McPherson, J. Robertson & B. Brody. Pharmacogenetics: Ethical Issues and Policy Options. Kennedy Institute of Ethics Journal 2002; 12: 1-15. My Very Own Medicine: What Must I Know? Information Policy for Pharmacogenetics. 2003. Cambridge. University of Cambridge Press; Nuffield Council on Bioethics. 2003. Pharmacogenetics: Ethical Issues. London. Nuffield Council on Bioethics; M. Rothstein, ed. 2003. Pharmacogenomics: Social, Ethical and Clinical Dimensions. New Jersey. Wiley-Liss, A John Wiley & Sons; N.W. Paul & A.D. Roses. Pharmacogenetics and Pharmacogenomics: Recent Developments, their Clinical Relevance and some Ethical, Social, and Legal Implications. Journal of Molecular Medicine 2003; 81: 135-140.
10. See for example: Consortium on Pharmacogenetics. 2002. Pharmacogenetics: Ethical and Regulatory Issues in Research and Clinical Practice; A. Buchanan, A. Califano, J. Kahn, E. McPherson, J. Robertson & B. Brody. Pharmacogenetics: Ethical Issues and Policy Options. Kennedy Institute of Ethics Journal 2002; 12: 1-15. My Very Own Medicine: What Must I Know? Information Policy for Pharmacogenetics. 2003. Cambridge. University of Cambridge Press; Nuffield Council on Bioethics. 2003. Pharmacogenetics: Ethical Issues. London. Nuffield Council on Bioethics; M. Rothstein, ed. 2003. Pharmacogenomics: Social, Ethical and Clinical Dimensions. New Jersey. Wiley-Liss, A John Wiley & Sons; N.W. Paul & A.D. Roses. Pharmacogenetics and Pharmacogenomics: Recent Developments, their Clinical Relevance and some Ethical, Social, and Legal Implications. Journal of Molecular Medicine 2003; 81: 135-140.
11. See for example: Consortium on Pharmacogenetics. 2002. Pharmacogenetics: Ethical and Regulatory Issues in Research and Clinical Practice; A. Buchanan, A. Califano, J. Kahn, E. McPherson, J. Robertson & B. Brody. Pharmacogenetics: Ethical Issues and Policy Options. Kennedy Institute of Ethics Journal 2002; 12: 1-15. My Very Own Medicine: What Must I Know? Information Policy for Pharmacogenetics. 2003. Cambridge. University of Cambridge Press; Nuffield Council on Bioethics. 2003. Pharmacogenetics: Ethical Issues. London. Nuffield Council on Bioethics; M. Rothstein, ed. 2003. Pharmacogenomics: Social, Ethical and Clinical Dimensions. New Jersey. Wiley-Liss, A John Wiley & Sons; N.W. Paul & A.D. Roses. Pharmacogenetics and Pharmacogenomics: Recent Developments, their Clinical Relevance and some Ethical, Social, and Legal Implications. Journal of Molecular Medicine 2003; 81: 135-140.
12. See for example: Consortium on Pharmacogenetics. 2002. Pharmacogenetics: Ethical and Regulatory Issues in Research and Clinical Practice; A. Buchanan, A. Califano, J. Kahn, E. McPherson, J. Robertson & B. Brody. Pharmacogenetics: Ethical Issues and Policy Options. Kennedy Institute of Ethics Journal 2002; 12: 1-15. My Very Own Medicine: What Must I Know? Information Policy for Pharmacogenetics. 2003. Cambridge. University of Cambridge Press; Nuffield Council on Bioethics. 2003. Pharmacogenetics: Ethical Issues. London. Nuffield Council on Bioethics; M. Rothstein, ed. 2003. Pharmacogenomics: Social, Ethical and Clinical Dimensions. New Jersey. Wiley-Liss, A John Wiley & Sons; N.W. Paul & A.D. Roses. Pharmacogenetics and Pharmacogenomics: Recent Developments, their Clinical Relevance and some Ethical, Social, and Legal Implications. Journal of Molecular Medicine 2003; 81: 135-140.